Fosun Pharmaceuticals
3:45 PM - 4:00 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 104B
Fosun Pharma is a gloabl pharmaceutical company
that is patient-centered and clinical needs-oriented. The company enriches its innovative product pipeline through diversified models such as independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma has formed technological platforms for innovative small molecule drugs, antibody drugs, and cell therapy with a focus on key disease areas including oncology and immunomodulation, metabolism and digestive system, and central nervous system. Fosun Pharma also vigorously explores cutting edge technologies to discover and deliver future breakthrough therapies in multiple therapeutic areas
that is patient-centered and clinical needs-oriented. The company enriches its innovative product pipeline through diversified models such as independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma has formed technological platforms for innovative small molecule drugs, antibody drugs, and cell therapy with a focus on key disease areas including oncology and immunomodulation, metabolism and digestive system, and central nervous system. Fosun Pharma also vigorously explores cutting edge technologies to discover and deliver future breakthrough therapies in multiple therapeutic areas
Ticker:
02196-HK
Exchange:
Hong Kong
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
New Jersey
Company HQ Country:
United States
Year Founded:
1994
Main Therapeutic Focus:
Multiline Global Biopharma
Lead Product in Development:
Serplulimab
Development Phase of Primary Product:
Phase III
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
